Table 1.
Case number | Age bracket | Speciality at admission | Specimen of first isolate | Subsequent clinical isolate (n days between screen and clinical isolate)a | Any antibiotic therapy prior to identification of NDM infectionb | CPE antibiotic therapy used post NDM identification | Initial colistin MIC (mg/L)c | Highest colistin MIC (mg/L)d | Colistin resistant at any stage |
---|---|---|---|---|---|---|---|---|---|
KP_NDM1 | 81–90 | Renal | Urine | — | Amikacin | No antibiotics | <0.05 | 8 | Yes |
KP_NDM2 | 51–60 | Vascular | Screening | Liver abscess (5) | Amikacin Metronidazole Piperacillin/Tazobactam Vancomycin | Colistimethate sodium Tigecycline | <0.05 | 16 | Yes |
KP_NDM3 | 81–90 | Orthopaedic | Urine | — | None identified | No antibiotics | <0.05 | ||
KP_NDM4 | 61–70 | Renal | Abdominal fluid | — | Ciprofloxacin Meropenem Metronidazole Piperacillin/Tazobactam Vancomycin | No antibiotics | <0.05 | 1 | |
KP_NDM5 | 51–60 | Vascular | Urine | — | None identified | No antibiotics | <0.05 | ||
KP_NDM6 | 61–70 | Cardiac | Wound (Leg) | — | Meropenem | Colistimethate sodium Tigecycline | Not done | <0.05 | |
KP_NDM7 | 71–80 | Renal | Screening | Leg swab and tissue, urine (22) | None identified | Colistimethate sodium Tigecycline | 4 | 8 | Yes |
KP_NDM8 | 71–80 | Vascular | Screening | None | None identified | No antibiotics | 32 | Yes | |
KP_NDM9 | 71–80 | Renal | Screening | Urine, central veneous catheter tip (4) | Meropenem | Colistimethate sodium Tigecycline, | 8 | Yes | |
KP_NDM10 | 71–80 | Renal | Screening | None | Nystatina | No antibiotics | <0.05 | ||
KP_NDM11 | 81–90 | Cardiac | Screening | None | None identified | Colistimethate sodium Tigecycline | 32 | Yes | |
KP_NDM12 | 61–70 | Renal | Screening and urine | — | Cotrimoxazoled | Colistimethate sodium Tigecycline | 8 | 8 | Yes |
KP_NDM13 | 61–70 | Cardiac | Screening | None | None identified | No antibiotics | 8 | Yes | |
KP_NDM14 | 81–90 | Cardiac | Screening | None | Cefalexin | No antibiotics | Not available | ||
KP_NDM15 | 61–70 | Cardiac | Screening | None | Amikacin Clarithromycin Co–amoxiclav Piperacillin/Tazobactam Vancomycin | No antibiotics | <0.05 | ||
KP_NDM16 | 81–90 | Renal | Screening | Groin wound swab (16) | Meropenem | Tigecycline | 8 | Yes | |
KP_NDM17 | 71–80 | Renal | Screening | Urine and mouth ulcers (235) | Co–amoxiclav Piperacillin/Tazobactam Vancomycin | Tigecycline | 16 | Yes | |
KP_NDM18 | 51–60 | Renal | Screening | None | Ciprofloxacin Cotrimoxazoled Metronidazole Piperacillin/Tazobactam, Vancomycin, | No antibiotics | 32 | Yes | |
KP_NDM19 | 81–90 | Renal | Screening | Urine (6) | Meropenem | Tigecycline | <0.5 | ||
KP_NDM20 | 71–80 | Renal | Screening | Wound swab (11) | None identified | No antibiotics | <0.5 | >32 | Yes |
KP_NDM21 | 51–60 | Renal | Screening | Urine (15) | None identified | No antibiotics | 1 | ||
KP_NDM22 | 61–70 | Renal | Screening | Urine (254) | None identified | No antibiotics | Not done | ||
KP_NDM23 | 61–70 | Vascular | Wound (surgical) | — | Ciprofloxacin, Vancomycin | No antibiotics | 32 | 16 | Yes |
KP_NDM24 | 61–70 | Cardiac | Screening | None | Co-amoxiclav Ciprofloxacin Vancomycin | No antibiotics | 4 | Yes | |
KP_NDM25 | 71–80 | Intensive Care | Screening | Wound swabs (groin and thigh) (28) | Metronidazole Piperacillin/Tazobactam Vancomycin | Colistimethate sodium Tigecycline | 4 | Yes | |
KP_NDM26 | 61–70 | Renal | Screening | None | Piperacillin/Tazobactam, Vancomycin | No antibiotics | 16 | Yes | |
KP_NDM27 | 21–30 | Intensive Care | Screening | None | Co-trimoxazoled Valganciclovird | No antibiotics | 16 | Yes | |
KP_NDM28 | 31–40 | Intensive Care | Screening | None | Amikacin Linezolid Liposomal amphotericin, | No antibiotics | 4 | Yes | |
KP_NDM29 | 71–80 | Vascular | Soft tissue and bone (foot) | — | Amikacin Piperacillin/ Tazobactam, Vancomycin, | No antibiotics | 8 | 2 | Yes |
KP_NDM30 | 61–70 | Cardiac | Screening | None | Ceftriaxone | Colistimethate sodium Tigecycline | 1 | ||
KP_NDM31 | 81–90 | Emergency Medicine | Screening | Urine (3) | Ceftriaxone Flucloxacillin Gentamycin, Metronidazole Rifampicin | No antibiotics | 8 | Yes | |
KP_NDM32 | 51–60 | Maternity | Screening | Urine (18) | Amikacin, Caspofungin Co-trimoxazoledd Ciprofloxacin Metronidazole, Vancomycin | No antibiotics | 8 | 8 | Yes |
KP_NDM33 | 51–60 | Intensive Care | Screening | Central veneous catheter tip, abdominal wound (5) | Co-trimoxazoled Meropenem, Nystatind | No antibiotics | 8 | Yes | |
KP_NDM34 | 21–30 | Renal | Screening | None | Piperacillin/Tazobactam | No antibiotics | 16 | Yes | |
KP_NDM35 | 51–60 | Renal | Soft tissue and bone (foot) | — | Ciprofloxacin, Clindamycin Vancomycin, | Colistimethate sodium, Tigecycline | <0.5 | ||
KP_NDM36 | 61–70 | Vascular | Screening | None | Anidulanfungin Meropene Rifaximin Vancomycin | No antibiotics | <0.5 | ||
KP_NDM37 | 91–100 | Vascular | Screening | None | Ceftriaxone | No antibiotics | <0.5 | ||
KP_NDM38 | 0–10 | Vascular | Screening | None | Benzylpenicillin Colistimethate sodium, Gentamicin | No antibiotics | 8 | Yes | |
KP_NDM39 | 51–60 | Vascular | Screening | None | None identified | Colistimethate sodium, Tigecycline | <0.5 | ||
KP_NDM40 | 61–70 | Vascular | Screening | None | Isoniazidd | No antibiotics | 8 | Yes |
aColumn denotes patients who were initially identified by screening, but had a subsequent clinical isolate, the site of the first clinical isolate, and the time between the screen and the first clinical isolate.
bIdentified through case note review/electronic pharmacy records for period 2014/15.
cBold font denotes colistin resistance (>2 mg/L).
dProphylaxis post-transplant as part of approved protocols.